Showing results (2591-2600 of 2,924) with videos related to

Sort By:
Pageof 293
Cancer Letters|April 6, 2023
The diverse pancreatic tumor cell-intrinsic response to IFNγ is determined by epigenetic heterogeneityYueyue Chen, Xuqing Shen, Yingying Tang, et al.
In Vitro Cellular & Developmental Biology. Animal|September 23, 2011
Human amniotic fluid-derived stem cells can differentiate into hepatocyte-like cells in vitro and in vivoHui Liu, Da-qing Liu, Bao-wei Li, et al.
Chemical Research in Toxicology|June 21, 2005
Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugatesCuyue Tang, Raju Subramanian, Yuhsin Kuo, et al.
Nature Materials|June 27, 2022
Intrinsic ferroelectricity in Y-doped HfO2 thin filmsYu Yun, Pratyush Buragohain, Ming Li, et al.
Cancer Biology & Medicine|March 16, 2021
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinomaYan Song, Juxiang Xiao, Wentao Fang, et al.
Cancer Research|July 10, 2012
BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinomaLixing Zhang, Hefen Sun, Fangyu Zhao, et al.
Nano Letters|June 6, 2024
Two-Dimensional Ultrathin Fe3Sn2 Kagome Metal with Defect-Dependent Magnetic PropertyManli Zhu, Qiuqiu Li, Kaiwen Guo, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 21, 2026
Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signalingHanzhong Zhang, Ying Liu, Wangzheqi Zhang, et al.
Journal of Microbiology and Biotechnology|January 23, 2014
Purification and characterization of a thermostable xylanase from Paenibacillus sp. NF1 and its application in xylooligosaccharides productionHong-chen Zheng, Ming-zhe Sun, Ling-cai Meng, et al.
Cancer Medicine|February 15, 2021
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trialJing Huang, Juxiang Xiao, Wentao Fang, et al.
Pageof 293